Punctal-Canalicular Stenosis Related to Systemic Fluorouracil Therapy
- 1 February 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 99 (2) , 284-286
- https://doi.org/10.1001/archopht.1981.03930010286013
Abstract
• This is, to our knowledge, the first report in the ophthalmic literature of punctal-canalicular stenosis and concomitant epiphora associated with the prolonged administration of fluorouracil; to our knowledge, fluorouracil is the first systemically administered agent to cause obstruction in the lacrimal system. Each of three patients receiving this antimetabolite alone and one patient receiving it in combination with methotrexate and cyclophosphamide were studied for complaints of epiphora. All four patients exhibited stenosis or occlusion of one or more puncta, while three also had one to four of their canaliculi stenosed. Two patients exhibited recurrent epiphora, beginning one to two days after each administration of fluorouracil and resolving in two to three days. One patient experienced amelioration of her symptoms after Silastic tube intubation of her canalicular system.This publication has 5 references indexed in Scilit:
- Lacrimation and 5-FluorouracilAnnals of Internal Medicine, 1978
- Tear-Duct Fibrosis (Dacryostenosis) Due to 5-FluorouracilAnnals of Internal Medicine, 1978
- The Diagnosis of the Causes of EpiphoraAmerican Journal of Ophthalmology, 1969
- Furmethide Iodide in the Production of Dacryostenosis*American Journal of Ophthalmology, 1951